October 11, 2022
UC San Diego scientists are leading a national early-stage clinical trial to assess the safety and efficacy of using bacteriophages to treat drug-resistant bacterial infections in cystic fibrosis patients.
November 25, 2013
Researchers at the University of California, San Diego School of Medicine have successfully targeted T lymphocytes – which play a central role in the body’s immune response – with another type of white blood cell engineered to synthesize and deliver bits of non-coding RNA or microRNA (miRNA).
October 12, 2017
…who suffer from liver diseases (cirrhosis, hepatitis B or hepatitis C), people who have clotting factor disorders, and those traveling to countries that have high hepatitis A rates. Health care, social and public health workers are also at increased risk. The vaccine is being provided to UC San Diego Health…
March 26, 2020
Researchers at University of California San Diego School of Medicine are launching a pair of studies to answer critical questions regarding the roles COVID-19 may play in breast milk and pregnancy.
October 10, 2011
…provided novel insights into disease mechanisms. Their work has opened up new avenues for the development of prevention and therapy against infections, cancer, and inflammatory diseases.” Beutler followed his older brother Earl to UC San Diego in 1974 at the age of only 16. “I was the third son and…
March 1, 2016
Chronic psychosocial and emotional stress has well-documented negative effects upon the human immune system but less is known about the health effects of acute but transitory episodes of stress. Do panic-inducing moments also raise the risk of stress-related conditions? A team of researchers at University of California, San Diego School…
April 30, 2012
William G. Bradley, Jr., MD, PhD, FACR, chairman of the Department of Radiology, was awarded the ACR Gold Medal and Honorary Fellowship, the highest honor of the American College of Radiology on April 22, during the ACR annual meeting and Chapter Leadership Conference held in Washington, D.C. The ACR said…
August 2, 2021
UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe.
December 28, 2022
UC San Diego study reveals critical insights into the complex biology of tissue-specific T cells, paving the way for a new branch of precision therapeutics in immunity, autoimmunity, and cancer.
January 23, 2020
…in understanding and treating infectious diseases with global health implications—conditions such as HIV and tuberculosis. For many Americans, “tuberculosis” might sound like something out of a Jane Austen novel; but to think that tuberculosis, or TB, is a disease from a bygone era would be a mistake. Today, it kills…
